Search Within

Charles Rudin

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (93)
  2. Meeting Abstract (66)
  3. Editorial (3)
  4. Research Letter (2)
  5. Guidelines (1)
  6. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (166)
  2. Department of Medicine (166)
  3. GSK Faculty (166)
  4. Human Oncology and Pathogenesis Program (166)
  5. Solid Tumor Oncology Division (166)
  6. Thoracic Oncology (166)

More Groups

People
  1. Marc Ladanyi (92)
  2. Mark Kris (63)
  3. Gregory Riely (61)
  4. Michael Berger (53)
  5. Maria Arcila (52)
  6. Natasha Rekhtman (52)

More People

Years
  1. 2025 (4)
  2. 2024 (17)
  3. 2023 (20)
  4. 2022 (25)
  5. 2021 (18)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (30)
  2. Journal of Thoracic Oncology (26)
  3. Clinical Cancer Research (16)
  4. Annals of Oncology (9)
  5. Modern Pathology (8)
  6. Cancer Discovery (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (37)
  2. Elsevier Inc. (29)
  3. American Association for Cancer Research (27)
  4. Nature Publishing Group (16)
  5. Cell Press (14)
  6. Oxford University Press (12)

More Publishers

Results (166)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Microsatellite instability and mismatch repair deficiency define a distinct subset of lung cancers characterized by smoking exposure, high tumor mutational burden, and recurrent somatic MLH1 inactivation
    Journal Article

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D. A.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benayed, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • CDC7 inhibition constrains lineage plasticity and prevents resistance and neuroendocrine transformation in the lung and prostate
    Meeting Abstract

    Quintanal-Villalonga, Á.; Zaidi, S.; Karthaus, W. R.; Zhan, Y. A.; Shafer, M.; Qiu, J.; de Stanchina, E.; Haffner, M. C.; Sawyers, C. L.; Rudin, C. M.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer
    Journal Article

    Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non–small cell lung cancer
    Journal Article

    Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Rizvi, H.; Elkrief, A.; Luo, J.; Alessi, J. V.; Pecci, F.; Lamberti, G.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Microsatellite instability defines a subset of lung cancers with smoking exposure, high tumor mutational burden and MLH1 inactivation
    Meeting Abstract

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benhamida, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Identifying early and late hallmarks of plasticity in neuroendocrine transformation of lung cancer at single-cell level
    Meeting Abstract

    Chan, J. M.; Quintanal-Villalonga, A.; Sabet, A.; Manoj, P.; Masilionis, I.; Falcon, C.; Sohail, N.; Chun, J.; Nawy, T.; Mazutis, L.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Exportin 1 inhibition constraints lineage plasticity and histological transformation through downregulation of SOX2
    Meeting Abstract

    Quintanal-Villalonga, A.; Durani, V.; Sabet, A.; Redin, E.; Kawasaki, K.; Shaffer, M.; Manoj, P.; Sridhar, H.; Haffner, M. C.; Sawyers, C. L.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • POT1 germline pathogenic variants and evolving understanding of tumor spectrum: Evidence for lung cancer predisposition
    Meeting Abstract

    Walsh, M. F.; Mukherjee, S.; Gao, M.; Fiala, E.; Mauguen, A.; Kemel, Y.; Bandlamudi, C.; Mehine, M.; Carlo, M. I.; Murciano-Goroff, Y. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and molecular features of long-term response to anti-PD-(L)1 therapy in patients with advanced non-small cell lung cancer
    Meeting Abstract

    Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Luo, J.; Alessi, J. V. M.; Pecci, F.; Lamberti, G.; Hong, Lingzhi; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Liu, D.; Makker, V.; Buonocore, D. J.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Johnson, A.; Offin, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save